Inspire Medical Systems Inc (INSP)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$120.25
Buy
$164.00
$3.32 (+2.12%)
Inspire Medical Systems Inc operates as a medical technology company. The firm develops implantable neurostimulation systems to treat obstructive sleep apnea.
Prices updated at 13 May 2025, 09:04 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
| Year | Gross margin (%) | Operating margin (%) | Net margin (%) | EBITDA margin (%) | EBITDA |
|---|---|---|---|---|---|
| 2024 | 84.68 | 4.49 | 6.67 | 8.10 | 65m |
| 2023 | 84.54 | -6.45 | -3.39 | -2.73 | -17m |
| 2022 | 83.79 | -11.67 | -11.00 | -9.99 | -41m |
| 2021 | 85.74 | -17.07 | -18.01 | -16.55 | -39m |
| 2020 | 84.73 | -48.72 | -49.58 | -46.91 | -54m |
| 2019 | 83.37 | -42.53 | -40.52 | -37.28 | -31m |
| 2018 | 80.12 | -40.28 | -43.14 | -35.84 | -18m |
| 2017 | 78.93 | -56.02 | -61.30 | -54.16 | -15m |
| 2016 | 76.23 | -105.03 | -112.79 | -104.23 | -17m |
Valuation data table
| Year | Price / Sales | Price earnings | Price / Cash flow |
|---|---|---|---|
| 2025 | 5.84 | 72.95 | 42.79 |
| 2024 | 7.44 | 167.01 | 71.72 |
| 2023 | 10.40 | - | 222.53 |
| 2022 | 20.01 | - | - |
| 2021 | 31.09 | - | - |
| 2020 | 49.51 | - | - |
| 2019 | 24.08 | - | - |
| 2018 | 20.54 | - | - |
Price/Forward earnings (YTD)
69.93
Returns
Debt profile
Returns data table
| Year | Return on assets (%) | Return on equity (%) | Return on invested capital (%) |
|---|---|---|---|
| 2024 | 7.21 | 8.48 | 4.88 |
| 2023 | -3.41 | -3.96 | -6.79 |
| 2022 | -10.44 | -12.38 | -12.38 |
| 2021 | -14.59 | -18.33 | -15.23 |
| 2020 | -24.74 | -30.96 | -26.58 |
| 2019 | -17.44 | -21.88 | -19.42 |
| 2018 | -19.39 | -94.45 | -46.56 |
| 2017 | -91.66 | - | - |
| 2016 | -141.26 | - | - |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 1.17 |
| 2023 | 1.18 |
| 2022 | 1.14 |
| 2021 | 1.29 |
| 2020 | 1.22 |
| 2019 | 1.30 |
| 2018 | 1.22 |
| 2017 | - |
| 2016 | - |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
